Login / Signup

The case for assessing the full value of new tuberculosis vaccines.

Nebiat GebreselassieRaymond HutubessyJohan VekemansSaskia den BoonTereza KasaevaMatteo Zignol
Published in: The European respiratory journal (2020)
Keyphrases
  • mycobacterium tuberculosis
  • pulmonary tuberculosis
  • adverse drug
  • hiv infected
  • electronic health record